Please find enclosed herewith the Un-audited Financial Results of the Company for the quarter and nine months ended 31st December, 2025 as approved by the Board.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 8.3 pts more than Nifty Microcap 250 and 8.6 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Narmada Gelatines reported strong Q3 FY26 results with standalone revenue from operations at Rs 5,673 lakhs, up 18.1% from Rs 4,802 lakhs a year ago. Standalone profit after tax jumped to Rs 740 lakhs (vs Rs 428 lakhs), translating to EPS of Rs 12.23 versus Rs 7.07. For the nine months ended December 2025, standalone revenue grew to Rs 15,371 lakhs and PAT rose to Rs 1,886 lakhs, compared to Rs 1,211 lakhs in the same period last year. Consolidated numbers were further boosted by share of profit from associate India Gelatine and Chemicals Limited, with consolidated 9M PAT at Rs 2,177 lakhs versus Rs 1,225 lakhs. Operating profit before tax and depreciation expanded sharply both quarterly and year-to-date, reflecting improved margin profile. The auditor (Lodha & Co LLP) issued an unqualified limited review report on both standalone and consolidated results.
Strong top-line growth coupled with significant PAT expansion (over 55% YoY for nine months) and margin improvement is a positive signal for shareholders and may support positive sentiment in the stock. The consolidation benefit from the IGCL associate adds a modest additional earnings tailwind.